跳到正文
原文
bioRxiv 预印本· Greenall, S. A., Chen, S. C., Alton, G., Beaton, G., Boelter, R., Casey, M., Babic, I., Bruce, Z. C., Garama, D. J., Mukthavaram, R., Tucci, F. C., Ravula, S. B., Lopez, A., Knowles, S., Stein, G. D., Li, Y., Stork, B., Dsouza, R. C. J., Kumar, A., Kittler, R., Tuma, A. C. M., Sarkaria, J. N., Gough, D. J., Stewart, R. A., Kesari, S., Day, B. W., Johns, T. G. ·· 29 天前AI 评分38

CT-179 抑制 OLIG2 破坏胶质母细胞瘤有丝分裂进程并增强放化疗疗效

Pharmacologic inhibition of OLIG2 by CT-179 disrupts mitotic progression and enhances standard-of-care chemoradiotherapy in glioblastoma

AI 导读

脑渗透性小分子 OLIG2 抑制剂 CT-179 在 11 株患者来源 GBM 细胞系中均抑制增殖(IC50 < 360 nM),通过分裂灾难、有丝分裂滑移等机制诱导凋亡并耗竭干样细胞群。

来源:bioRxiv 预印本 · biorxiv.org